Maysa Mustafa

Maysa Mustafa is an experienced professional in the medical device industry, currently serving as CEO of Ceretrieve since January 2017, where leadership encompasses fundraising, team management, and strategic direction for a novel neuro thrombectomy device. Maysa is also a member of the 8400 Health Network, participating in a prestigious HealthTech leadership program in collaboration with Harvard Business School. Previous roles include Product Manager at Bendit Technologies, Project Manager at West Pharmaceutical Services and Spring Health Solutions, and R&D Engineer at Elcam Medical, where responsibilities ranged from market research and product development to clinical trial management. Maysa holds a Bachelor of Science in Biomedical Engineering from the Technion - Israel Institute of Technology and an MBA from Tel Aviv University.